Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 2014. The document serves as a notification of transactions involving directors, persons discharging managerial responsibilities, or connected persons, specifically in compliance with DTR 3.1.4 R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific insider transaction and does not contain financial performance data.
Material Changes
The filing details a change in the shareholding interest of Mr. W Louv, a Person Discharging Managerial Responsibilities. On December 8, 2014, Mr. Louv sold 14,999.034 American Depositary Shares (ADSs) at a price of $45.86 per ADS.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the disclosed transaction.
Key Facts for Investor Verification
- Transaction Date: December 8, 2014
- Insider: Mr. W Louv (Person Discharging Managerial Responsibilities)
- Action: Sale of 14,999.034 ADSs
- Price: $45.86 per ADS
- Notification Date: December 11, 2014